Awardee OrganizationUNIVERSIDAD CENTRAL DEL CARIBE
Description
Abstract Text
The nicotinic acetylcholine receptor (AChR) from Torpedo californica
electric organ has a subunit stoichiometry of alpha2 beta gamma
delta. Its two acetylcholine-binding domains are located at the
alpha gamma and alpha delta subunit interfaces and display differing
affinities for certain competitive antagonists such as the cone snail
venom-derived peptides known as alpha-conotoxins. The long-term
objective of this research is to better understand the molecular
structure of these alpha-conotoxin binding sites. The hypothesis to
be tested in this project states: The segments of the gamma and delta
subunits shown to contribute to the alpha-conotoxin MI binding sites
on the Torpedo AChR where the residues are gamma K34/deltaS36,
gammaY111/deltaR113 and gammaH172/deltaI178. Differences in alpha-
conotoxin affinities result from residue differences at those
positions. This project will combine radiolabelled conotoxin binding
studies and electrophysiological studies on a cell line expressing
Torpedo californica AchR. The specific aims of the project are:
A. To synthesize radioiodinated alpha-conotoxins GI and EI to be
utilized in direct binding studies as two novel ligands specific for
the alpha gamma and alpha delta sites, respectively.
B. To characterize equilibrium binding and binding kinetics of 125I-
GI and 125I-EI to AchR prepared fromelectric organ tissue.
C. To characterize binding of 125I-GI and 125I-EI to cell-expressed
native (alpha2 betagamma2 and alpha2 betagamma2) AchR using both wild
type and mutant gamma and delta subunits. The gamma/delta
interchange mutants to be studied will include: gammaK34S, deltaS36K,
gammaY111R, deltaR113Y, gammaH172I and deltaI178H.
D. To use patch-clamp methodology to characterize agonist binding and
its inhibition by conotoxins GI and EI to the same cell-expressed
AchR molecules to be studied with direct radioligand binding.
This research should lad to a better understanding of the sructurally
similar vertebrate muscle AchR and of neuromuscular disease processes
involving this molecule.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
acetylcholinealternatives to animals in researchanimal poisoncalcium channel blockerscell linechemical bindingchimeric proteinselectrodeselectrophysiologyfish electric organneuromuscular blocking agentsneuromuscular functionneurotoxinsnicotinic receptorsprotein structure functionradionuclidesreceptor bindingreceptor expressionvoltage /patch clamp
No Sub Projects information available for 5S06GM050695-05 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5S06GM050695-05 0001
Patents
No Patents information available for 5S06GM050695-05 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5S06GM050695-05 0001
Clinical Studies
No Clinical Studies information available for 5S06GM050695-05 0001
News and More
Related News Releases
No news release information available for 5S06GM050695-05 0001
History
No Historical information available for 5S06GM050695-05 0001
Similar Projects
No Similar Projects information available for 5S06GM050695-05 0001